
<DOC>
<DOCNO>WT01-B03-193</DOCNO>
<DOCOLDNO>IA046-000815-B032-266</DOCOLDNO>
<DOCHDR>
http://www.gothic.net:80/people/5_2.htm 205.178.27.23 19970119002724 text/html 9598
HTTP/1.0 200 OK
Server: Microsoft-IIS/2.0
Date: Sun, 19 Jan 1997 00:30:25 GMT
Content-Type: text/html
Accept-Ranges: bytes
Last-Modified: Wed, 11 Sep 1996 00:17:32 GMT
Content-Length: 9400
</DOCHDR>
<HTML>
<HEAD>
   <TITLE>The Scientific Advisory Board</TITLE>
</HEAD>
<BODY BGCOLOR="#FFFFFF">

<P><MAP NAME="newnav"><AREA SHAPE=rect COORDS="396,1,440,12" HREF="../people/5_0.htm"><AREA SHAPE=poly COORDS="344,11,374,2,391,16,394,30,371,37,368,61,349,59,341,33,344,11" HREF="../people/5_0.htm"><AREA SHAPE=rect COORDS="435,54,495,65" HREF="../product/2_0.htm"><AREA SHAPE=poly COORDS="406,27,424,46,428,72,407,94,386,90,385,84,369,66,369,61,371,38,406,27" HREF="../product/2_0.htm"><AREA SHAPE=rect COORDS="393,114,525,124" HREF="../patent/4_0.htm"><AREA SHAPE=poly COORDS="330,75,366,64,384,86,390,110,366,134,334,126,325,103,330,75" HREF="../patent/4_0.htm"><AREA SHAPE=rect COORDS="205,75,271,96" HREF="../invest/6_0.htm"><AREA SHAPE=poly COORDS="313,56,329,74,324,102,327,110,313,123,286,117,273,91,279,65,313,56" HREF="../invest/6_0.htm"><AREA SHAPE=rect COORDS="196,30,282,41" HREF="../perform/3_0.htm"><AREA SHAPE=poly COORDS="291,28,323,16,338,34,345,58,330,72,313,54,290,61,286,49,291,28" HREF="../perform/3_0.htm"><AREA SHAPE=rect COORDS="8,2,105,25" HREF="../index.htm"><AREA SHAPE=rect COORDS="9,46,81,61" HREF="../contact.htm"><AREA SHAPE=rect COORDS="10,62,80,77" HREF="../search.htm"><AREA SHAPE=rect COORDS="10,78,79,93" HREF="../map.htm"></MAP><TABLE
BORDER=0 CELLPADDING=0 WIDTH=550>
   <TR>
      <TD>
         <P><IMG SRC="../images/newnav.gif" WIDTH=528 HEIGHT=136
         BORDER=0 ALIGN=bottom usemap="#newnav">
      </TD></TR>
   <TR>
      <TD>
         <P><MAP NAME="5"><AREA SHAPE=rect COORDS="235,61,300,74" HREF="5_0.htm"></MAP><IMG
         SRC="images/5_2.GIF" WIDTH=363 HEIGHT=109 BORDER=0
         ALIGN=bottom usemap="#5">
      </TD></TR>
</TABLE>

<P><TABLE BORDER=0 CELLPADDING=1 WIDTH=550>
   <TR>
      <TD>
         <BLOCKQUOTE><P><FONT SIZE=4>The Company has established
         relationships with a group of scientific advisors with
         expertise in their respective fields that align with Company
         sponsored programs. Each scientific advisory board member is
         responsible for a study or program relevant to the Company's
         data generation for FDA filings and approval. The Company
         holds formal semi-annual scientific advisory board meetings
         to review ongoing studies and exchange ideas. The Company's
         scientific advisors consult with management of the Company
         regarding the status of the Company's work in progress and
         the evaluation of prospective opportunities for the Company.
         </FONT>
         
         <P><FONT SIZE=4>The Company's scientific advisors include
         the following persons: </FONT>
         
         <P><B><I><FONT SIZE=4 COLOR="#DE2133">Joseph Rubinfeld,
         Ph.D.</FONT></I></B><FONT SIZE=4> Dr. Rubinfeld is Chairman
         of the Scientific Advisory Board. See
         "</FONT><I><FONT SIZE=4><A HREF="5_0.htm">Joe
         Rubinfeld</A></FONT></I><FONT SIZE=4>" </FONT>
         
         <P><B><I><FONT SIZE=4 COLOR="#DE2133">H. Leon Bradlow, Ph.D.
         </FONT></I></B><FONT SIZE=4> Dr. Bradlow is currently
         President of Amur Research Corp. and the Director of
         Laboratories at the Murray Raeburn Laboratory of
         Biochemistry and Endocrinology at Strang-Cornell Research
         Laboratory, as well as a Professor of Biochemistry in
         Surgery and Pediatrics at Cornell Medical School and
         Professor Emeritus at Rockefeller University and Albert
         Einstein College of Medicine. Dr. Bradlow served as editor
         of Steroids and has numerous publications in the fields of
         biochemistry, steroids, and the etiology of breast cancer.
         Since April 1992, in addition to serving on the Company's
         Scientific Advisory Board, Dr. Bradlow served as a
         Consulting Director of Natural Product Research from the
         Company's inception until December 1995. Dr. Bradlow
         received his Ph.D. from the University of Kansas. </FONT>
         
         <P><B><I><FONT SIZE=4 COLOR="#DE2133">Frank H. Gardner,
         M.D.</FONT></I><FONT SIZE=4 COLOR="#DE2133">
         </FONT></B><FONT SIZE=4>Dr. Gardner is a Clinical Professor
         of Medicine, Hematology and Oncology at the University of
         Texas Medical Branch in Galveston, Texas. He is a past
         Director of Medicine and of the Hematology Research
         Laboratory at the University of Pennsylvania Presbyterian
         Medical Center, has served as Associate Clinical Professor
         of Medicine at Harvard Medical School, and has been a
         Consultant in Medicine to the Surgeon General of the United
         States Army. Dr. Gardner has participated in numerous task
         forces, studies and committees, including the protocol
         studies of the Southwest Oncology Group, the Panel of
         Hematologic Agents, Drug Efficacy Study of the National
         Academy of Sciences and the National Breast Cancer Task
         Force of the National Cancer Institute. He is a former
         Scientific Counselor at the National Cancer Institute. Dr.
         Gardner received his M.D. from Northwestern University
         Medical School. </FONT>
         
         <P><B><I><FONT SIZE=4 COLOR="#DE2133">Harinder S. Juneja,
         M.D.</FONT></I><FONT SIZE=4 COLOR="#DE2133">
         </FONT></B><FONT SIZE=4>Dr. Juneja is an Associate Professor
         of Medicine at the University of Texas Health Science Center
         at Houston. He has extensive clinical and laboratory
         experience related to the Company's blood cell disorder
         projects, and his background is based in hematological
         diseases, and in particular leukemia and the bone marrow
         micro-environment. Dr. Juneja's current and past research
         support includes both the National Institutes of Health
         ("NIH") and the FDA. Dr. Juneja is a graduate of the All
         India Institute of Medical Sciences, New Delhi, India.
         </FONT>
         
         <P><B><I><FONT SIZE=4 COLOR="#DE2133">Joseph Kaplan,
         M.D.</FONT></I></B><FONT SIZE=4> Dr. Kaplan is a Professor
         of Pediatrics, Immunology, Microbiology and Medicine at
         Wayne State University School of Medicine, as well as being
         Director of Research at Children's Hospital of Michigan and
         Director of Clinical Immunology, Division of
         Hematology-Oncology at Wayne State University School of
         Medicine. He has served on several NIH committees. Dr.
         Kaplan's research has been focused on leukemia, bone marrow
         transplants and sickle cell anemia. He received his M.D.
         from Johns Hopkins School of Medicine. </FONT>
         
         <P><B><I><FONT SIZE=4 COLOR="#DE2133">Gerald Schochetman,
         Ph.D.</FONT></I><FONT SIZE=4 COLOR="#DE2133">
         </FONT></B><FONT SIZE=4>Dr. Schochetman is the Chief of the
         HIV Laboratory Investigations Branch, Division of AIDS, STD
         and TB Laboratory Research at the Centers for Disease
         Control and Prevention ("CDC"), Atlanta, Georgia and Adjunct
         Associate Professor of Pediatrics at Emory University School
         of Medicine. He was Department Head of Cell Biology and
         Immunology at Amgen and he was Vice President for Scientific
         Affairs at IGEN, Inc. Dr. Schochetman's current committee
         membership includes the World Health Organization ("WHO")
         Working Group on Vaccine Development, the National Institute
         of Allergies and Infectious Diseases ("NIAID") HIV Genetics
         Variation Committee, and the U.S. Public Health Service AIDS
         Vaccine Research and Development Subgroup. He received a
         B.S. from the City College of New York and his Ph.D. in
         Molecular Biology from the University of
         Pennsylvania.</FONT>
         
         <P><B><I><FONT SIZE=4 COLOR="#DE2133">Fred I. Chasalow,
         Ph.D.</FONT></I><FONT SIZE=4 COLOR="#DE2133">
         </FONT></B><FONT SIZE=4>Dr. Chasalow is currently the
         Scientific Director of Amur Research Corp. Previously, he
         served as Professor of Biochemistry in Pediatrics at the
         State University of New York (SUNY), Downstate, and Director
         of the Endocrine Laboratory and Chief of Pediatric Endocrine
         Research at Maimonides Medical Center in Brooklyn, New York.
         He is a current member of the Society for the Study of
         Reproduction, the Endocrine Society, the Clinical Ligand
         Assay Society, the American Society for Biological Chemistry
         and Molecular Biology, the Society for Pediatric Research,
         the International Growth Hormone Research Society and the
         Lawson Wilkins Pediatric Endocrine Society. Dr. Chasalow
         received his Ph.D. from Brandeis University. </FONT>
         </BLOCKQUOTE>
      </TD></TR>
</TABLE>

<P>&nbsp;

<P><MAP NAME="lowNAV"><AREA SHAPE=rect COORDS="67,10,111,19" HREF="../people/5_0.htm"><AREA SHAPE=rect COORDS="128,11,186,19" HREF="../product/2_0.htm"><AREA SHAPE=rect COORDS="204,11,336,19" HREF="../patent/4_0.htm"><AREA SHAPE=rect COORDS="353,11,403,19" HREF="../invest/6_0.htm"><AREA SHAPE=rect COORDS="420,11,504,19" HREF="../perform/3_0.htm"></MAP><IMG
SRC="../images/lowNAV.gif" WIDTH=530 HEIGHT=31 BORDER=0 ALIGN=bottom
usemap="#lowNAV">
</BODY>
</HTML>
</DOC>